ACHILLES THERAPEUTICS PL-ADR (ACHL) Institutional Ownership and Insiders Activity

ACHILLES THERAPEUTICS PL-ADR (ACHL) is widely held by institutional investors, with 3 firms reporting positions valued at approximately $98,851 based on SEC Form 13F filings for the quarter ended June 30, 2026.

Trium Capital Llp is the largest disclosed holder, reporting approximately $91,029 in ACHL holdings in its latest filing.

Institutional ownership remains highly concentrated, with Trium Capital Llp representing the majority of disclosed value.